![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Changzhou Pharmaceutical Factory Changzhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Atorvastatin calcium, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2015-034 - Rev 01
This Chemical Type CEP, issued on January 17, 2017, remains in force until November 02, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 2191 associated with this CEP further emphasizes